SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 145 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $40,000 | -56.0% | 1,615 | -0.2% | 0.01% | -36.8% |
Q1 2022 | $91,000 | -9.0% | 1,619 | 0.0% | 0.02% | -5.0% |
Q4 2021 | $100,000 | +96.1% | 1,619 | +102.4% | 0.02% | +81.8% |
Q3 2021 | $51,000 | -15.0% | 800 | 0.0% | 0.01% | -15.4% |
Q2 2021 | $60,000 | – | 800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 3,081,307 | $71,239,818 | 7.97% |
Finepoint Capital LP | 556,928 | $12,876,175 | 6.41% |
M28 Capital Management LP | 197,700 | $4,570,824 | 5.24% |
Boxer Capital, LLC | 3,421,541 | $79,106,028 | 4.21% |
Deep Track Capital, LP | 3,546,435 | $81,993,577 | 3.16% |
EcoR1 Capital, LLC | 3,460,208 | $80,000,009 | 2.70% |
Orbimed Advisors | 3,968,588 | $91,753,755 | 1.95% |
Artal Group S.A. | 1,816,620 | $42,000 | 1.80% |
SPHERA FUNDS MANAGEMENT LTD. | 319,911 | $7,396,342 | 1.35% |
Perceptive Advisors | 1,520,416 | $35,152,017 | 1.17% |